Literature DB >> 3087611

Optic neuritis and myelopathy in systemic lupus erythematosus.

S Oppenheimer, B I Hoffbrand.   

Abstract

The optic neuritis of systemic lupus erythematosus (S.L.E.) more frequently results in the persistence of a central scotoma or complete blindness after a single attack than demyelinating optic neuritis, although the initial clinical presentations may be identical. A significant number of patients, however, recover normal vision. Optic neuritis may be the presenting symptom of S.L.E. and as myelopathy may also occur in the course of the disease, confusion with multiple sclerosis may result, especially if there are no arthritic, cutaneous nor visceral manifestations. We report a case of lupus optic neuritis associated with anticardiolipin antibodies and a circulating lupus anticoagulant and suggest these may be a marker for vasculitic optic neuritis and play a role in its aetiology.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087611     DOI: 10.1017/s0317167100036064

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  11 in total

1.  Antiphospholipid antibodies and Mycoplasma pneumoniae infection.

Authors:  N Snowden; P B Wilson; M Longson; R S Pumphrey
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

Review 2.  Antiphospholipid antibody syndrome: a review.

Authors:  P J Bingley; B I Hoffbrand
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

3.  Prostacyclin in systemic lupus and anticardiolipin syndrome.

Authors:  R A Asherson; E N Harris; G R Hughes; J M Ritter; S E Barrow; M Jones
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

Review 4.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

5.  Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus.

Authors:  M F Cordeiro; M E Lloyd; D J Spalton; G R Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

6.  Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

Authors:  R A Asherson; D Mercey; G Phillips; N Sheehan; A E Gharavi; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

7.  Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide.

Authors:  J T Rosenbaum; J Simpson; C M Neuwelt
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

8.  Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature.

Authors:  Dan Carter; David Olchovsky; Hagit Yonath; Pnina Langevitz; David Ezra
Journal:  Clin Rheumatol       Date:  2005-10-19       Impact factor: 2.980

Review 9.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

10.  Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.

Authors:  Mohammad Adawi; Bishara Bisharat; Abdalla Bowirrat
Journal:  Clin Med Insights Case Rep       Date:  2014-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.